The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
evolved into an emergent global pandemic. Coronavirus disease 2019 (COVID‐19) can …

Clinically approved antiviral drugs are currently available for only 10 of the more than 220
viruses known to infect humans. The SARS-CoV-2 outbreak has exposed the critical need …

Here we report on the most recent updates on experimental drugs successfully employed in
the treatment of the disease caused by SARS-CoV-2 coronavirus, also referred to as COVID …

Historically, emerging viruses appear constantly and have cost millions of human lives.
Currently, climate change and intense globalization have created favorable conditions for …

Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging
infectious diseases; its efficacy was later associated with the evidence that polyclonal …

The present pandemic of SARS-CoV-2 has been a tough task for the whole world to deal
with. With the absence of specific drugs or vaccines against SARS-CoV-2, the situation is …

Ebola | New England Journal of Medicine Skip to main content The New England Journal of
Medicine homepage Advanced Search SEARCH The New England Journal of Medicine …

Plants provide not only food and feed, but also herbal medicines and various raw materials
for industry. Moreover, plants can be green factories producing high value bioproducts such …

In the last decade, carbon quantum dots (CQDs), as a novel class of carbon-based
nanomaterials, have received increasing attention due to their distinct properties. CQDs are …

Abstract Remdesivir (GS-5734), a viral RNA-dependent RNA polymerase (RdRP) inhibitor
that can be used to treat a variety of RNA virus infections, is expected to be an effective …